Recent Funding
Companies
Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

Health and bio Logistics and mobility GamingY Combinator

Latest funding

$60M Series A · March 24, 2026

Led by Satori Capital · Source: fundraisingfox.com

Total raised: $87M across 2 sourced rounds

All 3 rounds ↓

Website: gilgameshpharmaceutical.com.

X: @gilgameshrx · 577 followers.

LinkedIn: linkedin.com.

Categories: Health and bio Logistics and mobility Gaming.

Sectors: Healthcare, Drug Discovery and Delivery, Therapeutics, Psychedelics, Mental Health.

Stage: Series A.

Based in: New York City, United States.

Founded: 2019.

Total raised: $87M in 2 sourced rounds.

Last round: Mar 24, 2026 · 233 days ago.

Team: 15 people on the team page.

On Recent Funding since: Sep 28, 2026.

Signals

X account@gilgameshrx · created Aug 28, 2020 (6 years old) · 577 followers

Website registeredAug 24, 2019 (7 years old)

TIMELINE · MONEY RAISED

Gilgamesh Pharmaceuticals | 621 days from website to first raise on record

@gilgameshrx·Raised $87M in 2 sourced rounds·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

March 24, 2026
Series A · $60M
SSatori Capital (lead), AAlumni Ventures, PPrime Movers Lab
Source: fundraisingfox.com
May 6, 2021
Series A · $27M
PPrime Movers Lab (lead), AAlumni Ventures, GGaingels, GGron Ventures, JJLS Fund, NNoetic Fund, PPalo Santo Fund, RRoute 66 Ventures
Source: finance.yahoo.com
August 28, 2020
X account created
Summer 2020
YY Combinator · batch
Source: ycombinator.com
August 24, 2019
Website created

Founders and team

AK
Andrew Kruegel Founder

LinkedIn
DS
Dalibor Sames Co-Founder

LinkedIn · source: foundertrace.com
JW
Jeffrey Witkin Founder

LinkedIn
JS
Jonathan Sporn Founder

LinkedIn
MC
Mike Cunningham Founder
GM
Gerard Marek CMO
JA
Jorge A. Quiroz CDSO
LK
Laszlo Kiss CBO and Head of Research
YF
Yoni Falkson Chief Operating Officer

Investors

Companies like Gilgamesh Pharmaceuticals

SStorm Therapeutics$56M Series B+ · Apr 2026
IInnornaSeries B+ · Apr 2022
LLoyalSeries B+ · Mar 2026
CCellCentric$220M Series B+ · May 2026
PPsylink$580K Pre Seed · Jul 2025
CCity TherapeuticsSeries B+ · Aug 2026

Other companies backed by Satori Capital

NNextSense$16M Series A · Nov 2025

Satori Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/gilgamesh-pharmaceuticals (get a free API key).